Exagen (XGN) Return on Sales (2018 - 2026)

Exagen (XGN) has 9 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales grew to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2024 to a low of 0.02% in Q2 2022.
• A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales fell 2 bps — and 2023, when it gained 2 bps.
• Tracing XGN's Return on Sales over 5 years: stood at 0.01% in 2022, then soared by 65 bps to 0.0% in 2023, then gained by 29 bps to 0.0% in 2024, then dropped by 2 bps to 0.0% in 2025, then climbed by 18 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.